Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen HPV Test to be Used in Mexican Screening Program

NEW YORK (GenomeWeb News) – Qiagen today said that the Mexican Public Health Agency is launching a human papillomavirus screening program that will include the use of its Digene molecular HPV assay.
 
The agency will cover the cost of the test, which will be used to screen low-income women in the country between the ages of 35 and 65. During the first phase of the screening program, which will begin this month, more than 200,000 women in the 125 lowest-income counties are expected to be offered the HPV test along with a traditional Pap smear, said Qiagen.
 
Qiagen estimated that an estimated 6 million women will be eligible for the testing program in Mexico once it is rolled out on a national scale.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.